Cara Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. 

CEO
Christopher A. Posner
CEOChristopher A. Posner
Employees
55
Employees55
Headquarters
Stamford, Connecticut
HeadquartersStamford, Connecticut
Founded
2004
Founded2004
Employees
55
Employees55

CARA Key Statistics

Market cap
38.81M
Market cap38.81M
Price-Earnings ratio
-0.33
Price-Earnings ratio-0.33
Dividend yield
—
Dividend yield—
Average volume
388.27K
Average volume388.27K
High today
$0.73
High today$0.73
Low today
$0.6963
Low today$0.6963
Open price
$0.73
Open price$0.73
Volume
87.01K
Volume87.01K
52 Week high
$4.67
52 Week high$4.67
52 Week low
$0.50
52 Week low$0.50
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.